Roberts Eiry reported grant involving 1,506 derivative units of NEUROCRINE BIOSCIENCES INC at $0.00 for $0 on Nov 4, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Medical Officer
Chief Medical Officer
Filed Nov 5, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
1,506Restricted Stock Unit
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
1,506Direct
Trade date
Nov 4, 2026Grant
Filed
Nov 5, 2026, 4:10 PM ET1-day reporting delay
Accession
0001727606-26-000007Code A · Transaction 393467
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Grant8,314$0.00$0Trade 393466
2 transaction rows in this filing. Joint filers share the same rows.

NBIX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NBIX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −9.7%1w ago −8.9%1d ago −8.9%
Returns since7d +6%30d90d180d1y

Footnotes in full

F1: Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on December 4, 2026 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3: The Restricted Stock Units will settle annually at 1/4 of the units settling on each of November 4, 2027, November 4, 2028, November 4, 2029, and November 4, 2030.